No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CURV240621C5000
- 1.45
- +0.35+31.82%
15min DelayClose Jun 14 16:00 ET
1.45High1.30Low
1.30Open1.10Pre Close3 Volume55 Open Interest5.00Strike Price405.00Turnover239.43%IV-5.70%PremiumJun 21, 2024Expiry Date1.84Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8851Delta0.0949Gamma3.46Leverage Ratio-0.0352Theta0.0006Rho3.07Eff Leverage0.0017Vega
Intraday
- 5D
- 1D
News
Torrid Holdings First Quarter 2025 Earnings: EPS: US$0.12 (Vs US$0.11 in 1Q 2024)
Q1 2024 Torrid Holdings Inc Earnings Call
Why Torrid (CURV) Stock Is Down Today
Telsey Advisory Maintains Torrid(CURV.US) With Hold Rating, Raises Target Price to $8
Telsey Advisory analyst Dana Telsey maintains $Torrid(CURV.US)$ with a hold rating, and adjusts the target price from $6 to $8.According to TipRanks data, the analyst has a success rate of 43.2% and a
Netflix To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Piper Sandl
Torrid Holdings Is Maintained at Market Perform by Telsey Advisory Group
Torrid Holdings Is Maintained at Market Perform by Telsey Advisory Group
Comments
4/1/2024 🦍’s Watchlist 🚨⚡️🚨⚡️🚨⚡️🚨
$Yield10 Bioscience(YTEN.US$ $Lytus Technologies Holdings(LYT.US$ $Avalo Therapeutics(AVTX.US$ $Gamida Cell(GMDA.US$ $Torrid(CURV.US$ $Qilian International(QLI.US$
📊⚡️📊
$Yield10 Bioscience(YTEN.US$ $Lytus Technologies Holdings(LYT.US$ $Avalo Therapeutics(AVTX.US$ $Gamida Cell(GMDA.US$ $Torrid(CURV.US$ $Qilian International(QLI.US$
📊⚡️📊
3
ColumnsTorrid Holdings Gains More Than 25% After Hours After Plus-Sized Clothier Reports Narrower Q4 Loss
$Torrid(CURV.US$ rose more than 25% after hours Thursday after the plus-sized clothing maker beat analyst estimates for Q4 revenues and overall results.
CURV soared 26% to trade at $6.15 shortly before 4:45 p.m. ET after the company reported a $0.04 loss per share – narrower than the $0.07 analysts had reportedly expected.
The company also recorded $293.5 million of quarterly revenues vs. the $276....
CURV soared 26% to trade at $6.15 shortly before 4:45 p.m. ET after the company reported a $0.04 loss per share – narrower than the $0.07 analysts had reportedly expected.
The company also recorded $293.5 million of quarterly revenues vs. the $276....
2
The declining ROCE and revenue despite increased capital deployment is a concerning trend for Torrid Holdings. While the stock has performed well over the past year, these underlying trends do not bode well for its long-term performance.
Read more